Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 10,338

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus*·2002·Diabetes Care
DOI 10.2337/diacare.25.2007.s5
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.25.2007.s5

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 121

  1. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039–1057, 1979 · DOI · Paper page
  2. Hoet JJ, Tripathy BB, Rao RH, Yajnik CS: Malnutrition and diabetes in the tropics. Diabetes Care 19:1014–1017, 1996 · DOI
  3. Atkinson MA, Maclaren NK: The pathogenesis of insulin dependent diabetes. N Engl J Med 331:1428–1436, 1994 · DOI · Paper page
  4. Baekkeskov S, Neilsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A: Autoantibodies in newly diagnosed diabetic children with immunoprecipitate human pancreatic islet cell proteins. Nature 298:167–169, 1982 · DOI · Paper page
  5. Atkinson MA, Maclaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP: Are insulin autoantibodies markers for insulin-dependent mellitus? Diabetes 35: 894–898, 1986 · DOI
  6. Christie MR, Tun RY, Lo SSS, Cassidy D, Brown TJ, Hollands J, Shattock M, Bottazzo GF, Leslie RDG: Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM: studies with identical twins. Diabetes 41:782–787, 1992 · DOI
  7. Schott M, Schatz D, Atkinson M, Krischer J, Mehta H, Vold B, Maclaren N: GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus. J Autoimmunity 7:865–872, 1994 · DOI · Paper page
  8. Schmidli RS, Colman PG, Harrison LC: Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM? J Autoimmunity 7:873–879, 1994 · DOI
  9. Myers MA, Rabin DU, Rowley MJ: Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 44:1290–1295, 1995 · DOI
  10. Lan MS, Wasserfall C, Maclaren NK, Notkins AL: IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulindependent diabetes mellitus. Proc Natl Acad Sci USA 93:6367–6370, 1996 · DOI
  11. Lu J, Li Q, Xie H, Chen Z, Borovitskaya AE, Maclaren NK, Notkins AL, Lan MS: Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci USA 93: 2307–2311, 1996 · DOI
  12. Cantor AB, Krischer JP, Cuthbertson DD, Schatz DA, Riley WJ, Malone J, Schwartz S, Quattrin T, Maclaren NK: Age and family relationship accentuate the risk of IDDM in relatives of patients with insulin dependent diabetes. J Clin Endocrinol Metab 80:3739–3743, 1995 · DOI
  13. Huang W, Connor E, DelaRosa T, Muir A, Schatz D, Silverstein J, Crockett S, She JX, Maclaren NK: Although DR3-DQB1∗ may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB110302 haplotype is implicated only in beta cell autoimmunity. J Clin Endocrinol Metab 81:1–5, 1996 · DOI
  14. Zimmet PZ, Tuomi T, Mackay R, Rowley MJ, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299–303, 1994 · DOI · Paper page
  15. Banerji M, Lebovitz H: Insulin sensitive and insulin resistant variants in IDDM. Diabetes 38:784–792, 1989 · DOI
  16. Reaven GM, Bernstein R, Davis B, Olefsky JM: Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med 60:80–88, 1976 · DOI
  17. Olefsky JM, Kolterman OG, Scarlett, JA: Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol 243:E15–E30, 1982 · DOI
  18. Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM: Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest 68:957–969, 1981 · DOI · Paper page
  19. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G: Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 248:E286–E291, 1985 · DOI
  20. Kissebah AH, Vydelingum N, Murray R, Evans DF, Hartz AJ, Kalkhoff RK, Adams PW: Relationship of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254–260, 1982 · DOI · Paper page
  21. Butkiewicz EK, Leibson C, O’Brien PC, Palumbo PJ, Rizza RA: Insulin therapy for diabetic ketoacidosis. Diabetes Care 18:1187–1190, 1995 · DOI
  22. Umpierrez GE, Casals MMC, Gebhart SSP, Mizon PS, Clark WS, Phillips LS: Diabetic ketoacidosis in obese African-Americans. Diabetes 44:79–85, 1995 · DOI
  23. Harris MI: Impaired glucose tolerance in the U.S. population. Diabetes Care 12: 464–474, 1989 · DOI · Paper page
  24. Zimmet PZ: Kelly West Lecture 1991: challenges in diabetes epidemiology: from west to the rest. Diabetes Care 15:232–252, 1992 · DOI · Paper page
  25. Fujimoto WY, Leonetti DL, Kinyoun JL, Shuman WP, Stolov WC, Wahl PW: Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance or normal glucose tolerance. Diabetes 36:730–739, 1987 · DOI
  26. Moss SE, Klein R, Klein BEK, Meuer MS: The association of glycemia and cause-specific mortality in a diabetic population. Arch Int Med 154:2473–2479, 1984 · DOI
  27. Kuusisto J, Mykknen L, Pyörälä K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960–967, 1994 · DOI
  28. Andersson DKG, Svaardsudd K: Longterm glycemic control relates to mortality in type II diabetes. Diabetes Care 18: 1534–1543, 1995 · DOI
  29. Uusitupaa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K: Ten year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 11:1175–1184, 1993 · DOI · Paper page
  30. Polonsky KS, Sturis J, Bell GI: Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334:777–784, 1996 · DOI
  31. Scarlett JA, Gray RS, Griffin J, Olefsky JM, Kolterman OG: Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care 5:353–363, 1982 · DOI
  32. Firth RG, Bell PM, Rizza RM: Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 314:1280–1286, 1986 · DOI
  33. Simonson DC, Ferrannini E, Bevilacqua S, Smith D, Barrett E, Carlson R, DeFronzo RA: Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes 33:838–845, 1984 · DOI
  34. Henry RR, Wallace P, Olefsky JM: Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes 35:990–998, 1986 · DOI
  35. Wing RR, Blair EH, Bononi P, Marcus MD, Watanabe R, Bergman RN: Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 17:30–36, 1994 · DOI · Paper page
  36. Harris MI, Couric CC, Reiber G, Boyko E, Stern M, Bennett P (Eds.): Diabetes in America. 2nd ed. Washington, DC, U.S. Govt. Printing Office, 1995 (NIH publ. no. 95–1468)
  37. Newman B, Selby JV, Slemenda C, Fabsitz R, Friedman GD: Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30:763–738, 1987 · DOI · Paper page
  38. Barnett AH, Eff C, Leslie RDG, Pyke DA: Diabetes in identical twins. Diabetologia 20:87–93, 1981 · DOI · Paper page
  39. Herman WH, Fajans SS, Oritz FJ, Smith MJ, Sturis J, Bell GI, Polonsky KS, Halter JB: Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 43:40–46, 1994 · DOI
  40. Byrne MM, Sturis J, Menzel S, Yamagata K, Fajans SS, Dronsfield MJ, Bain SC, Hattersley AT, Velho G, Froguel P, Bell GI, Polonsky KS: Altered insulin secretory response to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45:1503–1510, 1996 · DOI
  41. Clement K, Pueyo ME, Vaxillaire M, Rakotoambinina B, Thuillier F, Passa P, Froguel P, Roberts J, Velho G: Assessment of insulin sensitivity in glucokinase-deficient subjects. Diabetologia 39:82–90, 1996 · DOI
  42. Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P, Beckman JS, Velho G, Lathrop GM, Froguel P: A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nature Genet 9:418–423, 1995 · DOI
  43. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southarm L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Bell GI: Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY 3). Nature 384:455–458, 1996 · DOI · Paper page
  44. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel MO, Lesage S, Vionnet N, Clement K, Fougerousse F, et al.: Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356:162–164, 1992 · DOI · Paper page
  45. Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H, Lesage S, Velho G, Iris F, Passa P, et al.: Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 356:721–722, 1992 · DOI · Paper page
  46. Bell GI, Xiang K, Newman MV, Wu S, Wright LG, Fajans SS, Spielman RS, Cox NJ: Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci 88:1484–1488, 1991 · DOI
  47. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the hepatocyte factor-4α gene in maturity-onset diabetes of the young (MODY 1). Nature 384:458–460, 1996 · DOI · Paper page
  48. Reardon W, Ross RJM, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC: Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340:1376–1379, 1992 · DOI · Paper page
  49. van den Ouwenland JMW, Lemkes HHPJ, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PAA, van de Kamp, Maassen JA: Mutation in mitochondrial tRNA (Leu(URR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genet 1:368–371, 1992 · DOI · Paper page
  50. Johns DR: Mitochondrial DNA and disease. N Engl J Med 333:638–644, 1995 · DOI
  51. Gruppuso PA, Gorden P, Kahn CR, Cornblath M, Zeller WP, Schwartz R: Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin. N Engl J Med 311:629–634, 1984 · DOI
  52. Robbins DC, Shoelson SE, Rubenstein AH, Tager HS: Familial hyperproinsulinemia: two cohorts secreting indistinguishable type II intermediates of proinsulin conversion. J Clin Invest 73:714–719, 1984 · DOI
  53. Tager H, Given B, Baldwin D, Mako M, Markese J, Rubenstein A, Olefsky J, Kobayashi M, Kolterman O, Poucher R: A structurally abnormal insulin causing human diabetes. Nature 281:122–125, 1979 · DOI
  54. Haneda M, Chan SJ, Kwok SCM, Rubenstein AH, Steiner DF: Studies on mutant human insulin genes: identification and sequence analysis of a gene encoding [SerB24]insulin. Proc Natl Acad Sci USA 80:6366–6370, 1983 · DOI
  55. Given BD, Mako ME, Tager HS, Baldwin D, Markese J, Rubenstein AH, Olefsky J, Kobayashi M, Kolterman O, Poucher R: Diabetes due to secretion of an abnormal insulin. N Engl J Med 302:129–135, 1980 · DOI
  56. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J: The syndromes of insulin resistance and acanthosis nigricans. N Engl J Med 294:739–745, 1976 · DOI · Paper page
  57. Taylor SI: Lilly Lecture: molecular mechanisms of insulin resistance: lessons from patients with mutations in the insulin-receptor gene. Diabetes 41:1473–1490, 1992 · DOI
  58. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T: Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41:1257–1266, 1992 · DOI
  59. Schwartz SS, Zeidler A, Moossa AR, Kuku SF, Rubenstein AH: A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma. Digestive Dis 23:1107–1114, 1978 · DOI
  60. Cersosimo E, Pister PWT, Pesola G, McDermott K, Bajorunas D, Brennan MF: Insulin secretion and action in patients with pancreatic cancer. Cancer 67:486–493, 1991 · DOI
  61. Larsen S, Hilsted J, Tronier B, Worning H: Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis. Metabolism 36:964–967, 1987 · DOI
  62. Phelps G, Chapman I, Hall P, Braund W, Mackinnon M: Prevalence of genetic haemochromatosis among diabetic patients. Lancet i i:233–234, 1989 · DOI
  63. Handwerger S, Roth J, Gorden P, Di Sant’ Agnese P, Carpenter DF, Peter G: Glucose intolerance in cystic fibrosis. N Engl J Med 281:451–461, 1969 · DOI
  64. Yajnik CS, Shelgikar KM, Naik SS, Kanitkar SV, Orskov H, Alberti KGMM, Hockaday TDR: The ketoacidosis-resistance in fibro-calculous-pancreatic-diabetes. Diabetes Res Clin Pract 15:149–156, 1992 · DOI
  65. Soffer LJ, Iannaccone A, Gabrilove JL: Cushing’s syndrome. Am J Med 30:129–146, 1961 · DOI
  66. Stenstrom G, Ernest I, Tisell L: Long-term results in 64 patients operated upon for pheochromocytoma. Acta Med Scan 223:345–352, 1988 · DOI
  67. Berelowitz M, Eugene HG: Non-insulin dependent diabetes mellitus secondary to other endocrine disorders. In Diabetes Mellitus. LeRoith D, Taylor SI, Olefsky JM, Eds. New York, Lippincott-Raven, 1996, p. 496–502
  68. Pandit MK, Burke J, Gustafson AB, Minocha A, Peiris AN: Drug-induced disorders of glucose tolerance. Ann Int Med 118:529–540, 1993 · DOI
  69. O’Byrne S, Feely J: Effects of drugs on glucose tolerance in non-insulin-dependent diabetes (parts I and II). Drugs 40:203–219, 1990 · DOI
  70. Bouchard P, Sai P, Reach G, Caubarrere I, Ganeval D, Assan R: Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes 31:40–45, 1982 · DOI
  71. Assan R, Perronne C, Assan D, Chotard L, Mayaud C, Matheron S, Zucman D: Pentamidine-induced derangements of glucose homeostasis. Diabetes Care 18:47–55, 1995 · DOI · Paper page
  72. Gallanosa AG, Spyker DA, Curnow RT: Diabetes mellitus associated with autonomic and peripheral neuropathy after Vacor poisoning: a review. Clin Toxicol 18:441–449, 1981 · DOI
  73. Esposti MD, Ngo A, Myers MA: Inhibition of mitochondrial complex I may account for IDDM induced by intoxication with rodenticide Vacor. Diabetes 45:1531–1534, 1996 · DOI
  74. Fabris P, Betterle C, Floreani A, Greggio NA, de Lazzari F, Naccarato R, Chiaramonte M: Development of type 1 diabetes mellitus during interferon alpha therapy for chronic HCV hepatitis. Lancet 340:548, 1992 · DOI
  75. Shiba T, Morino Y, Tagawa K, Fujino H, Unuma T: Onset of diabetes with high titer anti-GAD antibody after IFN therapy for chronic hepatitis. Diabetes Res Clin Pract 30:237–241, 1996 · DOI
  76. Forrest, JA, Menser MA, Burgess JA: High frequency of diabetes mellitus in young patients with congenital rubella; Lancet i i:332–334, 1971 · DOI
  77. King ML, Bidwell D, Shaikh A, Voller A, Banatvala JE: Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet i:1397–1399, 1983 · DOI · Paper page
  78. Karjalainen J, Knip M, Hyoty H, Linikki P, Ilonen J, Kaar M-L, Akerblom HK: Relationship between serum insulin antibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type I (insulin-dependent) diabetes. Diabetologia 31:146–152, 1988 · DOI
  79. Pak CY, Eun H, McArthur RG, Yoon J: Association of cytomegalovirus-infection with autoimmune type 1 diabetes. Lancet i i:1–4, 1988 · DOI · Paper page
  80. Rimoin DL: Genetic syndromes associated with glucose intolerance. In The Genetics of Diabetes Mellitus. Berlin, Springer-Verlag, 1976 · DOI
  81. Barrett TG, Bundey SE, Macleod AF: Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 346:1458–1463, 1995 · DOI · Paper page
  82. Engelgau MM, Herman WH, Smith PJ, German RR, Aubert RE: The epidemiology of diabetes and pregnancy in the U.S., 1988. Diabetes Care 18:1029–1033, 1995 · DOI
  83. Langer O, Rodriguez DA, Xenakis EMJ, McFarland MB, Berkus MD, Arrendondo F: Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol 170:1036–1047, 1994 · DOI
  84. Magee MS, Walden CE, Benedetti TJ: Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. JAMA 269:609–615, 1993 · DOI · Paper page
  85. O’Sullivan JB, Mahan CM: Criteria for the oral glucose tolerance test in pregnancy. Diabetes 13:278, 1964 · DOI
  86. O’Sullivan JB: The Boston Gestational Diabetes Studies: review and perspective. In Carbohydrate Metabolism in Pregnancy and the Newborn. Sutherland HW, Stowers JM, Pearson DWM, Eds. London, Springer-Verlag, 1989, p. 187–294 · DOI
  87. O’Sullivan JB: Diabetes after GDM. Diabetes 40(Suppl. 2):131–135, 1991 · DOI · Paper page
  88. Metzger BE, Cho NH, Roston SM, Radvany R: Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 16:1598–1605, 1993 · DOI · Paper page
  89. Coustan DR, Carpenter MW, O’Sullivan PS, Carr SR: Gestational diabetes: predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol 168: 1139–1145, 1993 · DOI · Paper page
  90. Kjos SL, Buchanan TA, Greenspoon JS, Montoro M, Bernstein GS, Mestman JH: Gestational diabetes: the prevalence of glucose intolerance and diabetes mellitus in the first two months postpartum. Am J Obstet Gynecol 163:93–98, 1990 · DOI
  91. Diabetes and pregnancy. In ACOG Technical Bulletin 200, 1994
  92. Sacks DA, Abu-Fadil S, Greenspoon JS: Do the current standards for glucose tolerance testing in pregnancy represent a valid conversion of O’Sullivan’s original criteria? Am J Obstet Gynecol 161:638–641, 1989 · DOI
  93. Naylor CD, Sermer M, Chen E, Sykora K: Caesarean delivery in relation to birth weight and gestational glucose tolerance. JAMA 275:1265–1270, 1996 · DOI · Paper page
  94. Pettitt DJ, Bennett PH, Hanson RL, Narayan KMV, Knowler WC: Comparison of World Health Organization and National Diabetes Data Group procedures to detect abnormalities of glucose tolerance during pregnancy. Diabetes Care 17:1264–1268, 1994 · DOI
  95. Deerochanawong C, Putiyanum C, Wongsuryrat M, Serirat S, Jinayon P: Comparison of National Diabetes Data Group and World Health Organization criteria for detecting gestational diabetes mellitus. Diabetologia 39:1070–1073, 1996 · DOI
  96. Metzger BE, Coustan DR: Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 21 (Suppl. 2):B161–B167, 1998
  97. Marquette GP, Klein VR, Niebyl JR: Efficacy of screening for gestational diabetes. Am J Perinatology 2:7–14, 1985 · DOI
  98. Dietrich ML, Dolnicek TF, Rayburn WR: Gestational diabetes screening in a private, midwestern American population. Am J Obstet Gynecol 156:1403–1408, 1987 · DOI
  99. Charles MA, Fontboune A, Thibult N, Warnet JM, Rosselin GE, Eschwege E: Risk factors for NIDDM in white population: Paris Prospective Study. Diabetes 40:796–799, 1991 · DOI
  100. Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensink JW, Bierman EL, Porte D Jr: Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 42:222–229, 1976 · DOI · Paper page
  101. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Coronary-heart disease risk and impaired glucose tolerance: the Whitehall Study. Lancet i:1373–1376, 1980 · DOI · Paper page
  102. Charles MA, Balkau B, Vauzelle-Kervöeden F, Thibult N, Eschwège E: Revision of diagnostic criteria for diabetes (Letter). Lancet 348:1657–1658, 1996 · DOI
  103. Jarrett RJ, Kahn H: Hyperglycemia and diabetes mellitus. Lancet i i:1009–1012, 1976 · DOI
  104. Klein R, Comor EB, Blount BA, Wingard DL: Visual impairment and retinopathy in people with normal glucose tolerance, impaired glucose tolerance and newly diagnosed NIDDM. Diabetes Care 14:914–918, 1991 · DOI
  105. Reaven GM, Olefsky J, Farquhar JW: Does hyperglycemia or hyperinsulinaemia characterize the patient with chemical diabetes? Lancet i:1247–1249, 1972 · DOI
  106. Little RR, England JD, Wiedmeyer H-M, McKenzie EM, Pettit DJ, Knowler WC, Goldstein DE: Relationship of glycosylated hemoglobin to oral glucose tolerance: implications for diabetes screening. Diabetes 37:60–64, 1988 · DOI
  107. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595–607, 1988 · DOI · Paper page
  108. McCance, DR, Hanson RL, Pettitt DJ, Bennett PH, Hadden DR, Knowler WC: Diagnosing diabetes mellitus: do we need new criteria? Diabetologia 40:247–255, 1997 · DOI
  109. Knowler, WC: Screening for NIDDM: opportunities for detection, treatment and prevention. Diabetes Care 17:445–450, 1994 · DOI
  110. Stolk RP, Orchard TJ, Grobbee DE: Why use the oral glucose tolerance test? Diabetes Care 18:1045–1049; 1995 · DOI
  111. Jackson CA, Yudkin JS, Forrest RD: A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community: the Islington Diabetes Survey. Diabetes Res Clin Pract 17:111–123, 1992 · DOI
  112. Beks PJ, Mackay AJC, de Neeling JND, de Vries H, Bouter LM, Heine RJ: Peripheral arterial disease in relation to glycaemic level in elderly Caucasian population: the Hoorn Study. Diabetologia 38:86–96, 1995 · DOI
  113. Finch CF, Zimmet PA, Alberti KGMM: Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabet Med 7:603–610, 1990 · DOI
  114. Peters AL, Davidson MB, Schriger DL, Hasselblad V, the Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels 1996: A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycated hemoglobin levels. JAMA 276:1246–1252, 1996 · DOI · Paper page
  115. American Diabetes Association: Tests of glycemia in diabetes (Position Statement). Diabetes Care 25(Suppl. 1):S97–S99, 2002 · DOI
  116. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 25(Suppl. 1):S33–S49, 2002 · DOI · Paper page
  117. Mayrhofer M, Rabin DU, Messenger L, Standl E, Ziegler AG: Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes. Exp Clin Endocrinol Diab 104:228–234, 1996 · DOI
  118. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte M-T, Bottazzo G-F, Gale EAM: Combined analyses of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304–1310, 1994 · DOI
  119. Verge CF, Gianani R, Kawasaki E, Chase H, Eisenbarth GS: Prediction of type 1 diabetes in first degree relatives using a combination of insulin, GAD and ICA512bc/ IA-2 autoantibodies. Diabetes 45:926–933, 1996 · DOI · Paper page
  120. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dahlquist G, Palmer J, Lernmark A: Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95:1505–1511, 1995 · DOI
  121. Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258–268, 1995 · DOI · Paper page

Cited by

See all 10,338

Metadata

Authors
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus*
Venue
Diabetes Care
Publisher
American Diabetes Association
Published
2002-01-01
Volume
25
Issue
suppl_1
Pages
s5-s20
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
DOI
10.2337/diacare.25.2007.s5
OpenAlex
W2345903479
Cited by
10,338
References
15
FWCI
404.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.